These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35030298)

  • 1. TP53 inhibitor PFTα increases the sensitivity of arsenic trioxide in TP53 wildtype tumor cells.
    Wang H; Wang X; Xu L; Zhang J
    FEBS Open Bio; 2022 Mar; 12(3):616-626. PubMed ID: 35030298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.
    Boyko-Fabian M; Niehr F; Distel L; Budach V; Tinhofer I
    PLoS One; 2014; 9(6):e98867. PubMed ID: 24927258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
    Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
    J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
    Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
    J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL.
    Liu Q; Hilsenbeck S; Gazitt Y
    Blood; 2003 May; 101(10):4078-87. PubMed ID: 12531793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide.
    Chien CW; Yao JH; Chang SY; Lee PC; Lee TC
    Toxicol Appl Pharmacol; 2011 Nov; 257(1):59-66. PubMed ID: 21889949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
    Lam SK; Leung LL; Li YY; Zheng CY; Ho JC
    Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
    Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y
    Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin promotes ATO-induced apoptosis in MCF-7 cells: Proposing novel therapeutic potential for breast cancer.
    Nooshinfar E; Bashash D; Safaroghli-Azar A; Bayati S; Rezaei-Tavirani M; Ghaffari SH; Akbari ME
    Biomed Pharmacother; 2016 Oct; 83():456-465. PubMed ID: 27427852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
    Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
    Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic Trioxide inhibits Activation of Hedgehog Pathway in Human Neuroblastoma Cell Line SK-N-BE(2) Independent of Itraconazole.
    Liu X; Wang Z; Xiong X; Li C; Wu Y; Su M; Yang S; Zeng M; Weng W; Huang K; Zhou D; Fang J; Xu L; Li P; Zhu Y; Qiu K; Ma Y; Lei J; Li Y
    Anticancer Agents Med Chem; 2023; 23(20):2217-2224. PubMed ID: 37888819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM2-mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53.
    Wang YS; Yin JZ; Shi XQ; Zhao XW; Li B; Yang MH
    Anticancer Agents Med Chem; 2023; 23(16):1829-1837. PubMed ID: 37259217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways.
    Lunghi P; Giuliani N; Mazzera L; Lombardi G; Ricca M; Corradi A; Cantoni AM; Salvatore L; Riccioni R; Costanzo A; Testa U; Levrero M; Rizzoli V; Bonati A
    Blood; 2008 Sep; 112(6):2450-62. PubMed ID: 18583568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double-strand break repair.
    Kryeziu K; Jungwirth U; Hoda MA; Ferk F; Knasmüller S; Karnthaler-Benbakka C; Kowol CR; Berger W; Heffeter P
    Mol Cancer Ther; 2013 Jun; 12(6):1073-84. PubMed ID: 23548265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligase.
    Yan W; Jung YS; Zhang Y; Chen X
    PLoS One; 2014; 9(8):e103497. PubMed ID: 25116336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum stress-mediated apoptosis in imatinib-resistant leukemic K562-r cells triggered by AMN107 combined with arsenic trioxide.
    Xia Y; Fang H; Zhang J; Du Y
    Exp Biol Med (Maywood); 2013 Aug; 238(8):932-42. PubMed ID: 23883479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
    Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism.
    Doudican NA; Bowling B; Orlow SJ
    Leuk Res; 2010 Feb; 34(2):229-34. PubMed ID: 19540589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells.
    Lunghi P; Costanzo A; Levrero M; Bonati A
    Blood; 2004 Jul; 104(2):519-25. PubMed ID: 15031205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of thymidylate synthase and E2F1 by arsenic trioxide in mesothelioma.
    Lam SK; Li YY; Zheng CY; Ho JC
    Int J Oncol; 2015 Jan; 46(1):113-22. PubMed ID: 25335113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.